Linked from
The 36 pages that link to Atopic dermatitis, each with the reason it gives.
Contact dermatitisCompared with: It can resemble contact dermatitis but is not defined by a specific contact exposure.
Skin barrierRelated: Barrier impairment and inflammation reinforce one another in this disease.
EpidermisRelated: Barrier disruption in the epidermis contributes to dryness and heightened sensitivity.
AllergyBroader topic: It commonly occurs within the broader pattern of allergic or atopic disease.
PsoriasisCompared with: It can resemble psoriasis, but its typical distribution and biology differ.
Stratum corneumRelated: Barrier defects in this disease can increase water loss and irritant penetration.
Allergic contact dermatitisCompared with: It can resemble contact dermatitis, but its pattern and underlying causes differ.
PruritusBroader topic: It is a common skin condition in which itch is a central symptom.
UrticariaCompared with: Its persistent eczematous patches differ from transient urticarial wheals.
KeratinocyteRelated: Keratinocyte barrier defects and inflammatory signaling contribute to the disease.
EmollientBroader topic: Emollients are a foundational part of daily skin care for reducing dryness in this condition.
ScabiesCompared with: It can resemble scabies, but it is not caused by a contagious mite infestation.
Skin microbiomeRelated: Flare-ups often coincide with reduced microbial diversity and increased Staphylococcus aureus.
Topical corticosteroidRelated: Topical corticosteroids are commonly used to control its inflammatory flares.
DermatologyBroader topic: It is a common condition linking impaired barrier function with immune-driven inflammation.
EczemaBroader topic: It illustrates eczema’s characteristic interaction between itch, inflammation, and barrier dysfunction.
Immunoglobulin ERelated: IgE levels are often elevated, though the disease is not explained by IgE alone.
Alopecia areataRelated: Atopic disease occurs more often in people with alopecia areata.
Post-inflammatory hyperpigmentationRelated: Repeated eczema inflammation can leave areas of darker pigmentation.
TacrolimusRelated: Topical tacrolimus treats inflammation without the skin atrophy associated with prolonged topical corticosteroid use.
DermatitisBroader topic: It combines barrier dysfunction with immune inflammation and recurring itch.
HumidifierRelated: Dry air can worsen skin dryness, though a humidifier does not treat the underlying condition.
Skin careRelated: Barrier-focused skin care can help reduce dryness and support medical treatment.
MoisturizerRelated: Regular moisturization helps manage dryness and support the impaired skin barrier.
Immunosuppressive drugBroader topic: Selected immunosuppressive medicines treat severe disease when other measures are insufficient.
BetamethasoneRelated: Topical betamethasone may be prescribed for flares when its potency is appropriate for the site and severity.
IchthyosisCompared with: Its episodic itchy inflammation differs from the persistent scale typical of ichthyosis.
Keratosis pilarisRelated: It can coexist with keratosis pilaris and is associated with dry, sensitive skin.
Human skinRelated: It exposes unresolved links among barrier defects, immunity, and microbial communities.
Integumentary systemBroader topic: Its impaired barrier illustrates the consequences of disrupted skin protection.
CiclosporinRelated: Systemic ciclosporin can control severe disease when other treatments are insufficient.
Flour miteRelated: Mite allergens can aggravate symptoms in some people with this condition.
Integumentary System Physiological PhenomenaBroader topic: It shows how impaired barrier function and immune activity can reinforce each other.
Periorbital dark circlesRelated: Eyelid inflammation and rubbing can contribute to persistent pigment changes.
Skin and Connective Tissue DiseasesBroader topic: It illustrates how barrier dysfunction and immune activity can combine in skin disease.
Skin conditionBroader topic: It is a common example of a condition involving barrier dysfunction and inflammation.